- Home
- SIGA vs THW Comparison
SIGA vs THW Comparison
Compare SIGA & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- THW
- Stock Information
- Founded
- SIGA 1995
- THW 2015
- Country
- SIGA United States
- THW United States
- Employees
- SIGA N/A
- THW N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- THW Finance Companies
- Sector
- SIGA Health Care
- THW Finance
- Exchange
- SIGA Nasdaq
- THW Nasdaq
- Market Cap
- SIGA 594.3M
- THW 504.3M
- IPO Year
- SIGA 1997
- THW N/A
- Fundamental
- Price
- SIGA $5.84
- THW $12.47
- Analyst Decision
- SIGA
- THW
- Analyst Count
- SIGA 0
- THW 0
- Target Price
- SIGA N/A
- THW N/A
- AVG Volume (30 Days)
- SIGA 466.5K
- THW 149.9K
- Earning Date
- SIGA 11-06-2025
- THW 01-01-0001
- Dividend Yield
- SIGA 10.40%
- THW 10.76%
- EPS Growth
- SIGA N/A
- THW N/A
- EPS
- SIGA 1.03
- THW N/A
- Revenue
- SIGA $172,249,641.00
- THW N/A
- Revenue This Year
- SIGA N/A
- THW N/A
- Revenue Next Year
- SIGA $115.06
- THW N/A
- P/E Ratio
- SIGA $5.67
- THW N/A
- Revenue Growth
- SIGA N/A
- THW N/A
- 52 Week Low
- SIGA $4.95
- THW $9.76
- 52 Week High
- SIGA $9.62
- THW $14.89
- Technical
- Relative Strength Index (RSI)
- SIGA 23.55
- THW 45.87
- Support Level
- SIGA $5.80
- THW $12.46
- Resistance Level
- SIGA $6.05
- THW $12.75
- Average True Range (ATR)
- SIGA 0.33
- THW 0.23
- MACD
- SIGA -0.11
- THW -0.01
- Stochastic Oscillator
- SIGA 5.45
- THW 59.37
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.